EN
HI
Dr Reddy's Laboratories Chart
Dr Reddy's Laboratories. Share Key Metrics
Volume
1.64 CR
Market Cap
111090.99 CR
LTQ@LTP
15@1331.00
ATP
1314.74
Var Margin
12.5 %
Circuit Range
1095.3-1338.7
Delivery %
60.98 %
Value
2157.19 CR
ASM/GSM
No
Market Lot
1
Summary
Dr Reddy's Laboratories. share price stands at ₹1331 at 23 Apr, 2026 | 15:55. The stock Dr Reddy's Laboratories. intraday movement has stayed between ₹1217.50 and ₹1357.00, while on a 52-week basis it has fluctuated from ₹1129.40 to ₹1379.70.
In terms of trading activity, Dr Reddy's Laboratories. has recorded a volume of 16407707 shares. The Dr Reddy's Laboratories. has a market cap of ₹834643020. The stock’s Average Traded Price (ATP) stands at ₹131474, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15, 133100.
The Dr Reddy's Laboratories. operates within a circuit range of ₹1095.3-1338.7 – ₹1095.3-1338.7, with a Value of ₹2157.19 CR. The Delivery Percentage for the day is 60.98%. Additionally, Dr Reddy's Laboratories. currently falls under the No framework, and trades with a market lot size of 1.
Dr Reddy's Laboratories. Fundamentals
View MoreP/E Ratio
18.24
P/B Ratio
2.73
Div. Yield
0.66
Sector P/E
64.34
Sector P/B
3.51
Sec. Div. Yield
0.57
Dr Reddy's Laboratories. Resistance and Support
Pivot 1217.03
Resistance
First Resistance
1225.96
Second Resistance
1234.93
Third Resistance
1243.86
Support
First Support
1208.06
Second Support
1199.13
Third Support
1190.16
Dr Reddy's Laboratories. Futures & Options
Dr Reddy's Laboratories. Option Chain
View Price, OI, Greeks & More...
28APR26
1323.80
112.90 (9.32%)
26MAY26
1310.20
100.20 (8.28%)
30JUN26
1316.90
102.30 (8.42%)
DRREDDY|28APR26 CE 1330.00
20.20
19.85 (5671.43%)
DRREDDY|28APR26 PE 1340.00
34.05
-91.85 (-72.95%)
Dr Reddy's Laboratories. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results |
| 2026-01-21 | Quarterly Results |
| 2025-10-24 | Quarterly Results |
| 2025-07-23 | Quarterly Results |
| 2025-05-09 | Audited Results |
| 2025-01-23 | Quarterly Results |
Dr Reddy's Laboratories. News
Dr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation For Recommending Final Dividend, If Any, For The Financial Year 2025-26
Dr. Reddy's Laboratories board will consider recommending a final dividend for FY 2025-26. This decision will be made during an upcoming board meeting, following a prior intimation from March 23, 2026.
Apr 16 2026 15:04:00
Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Sale Of Wholly Owned Subsidiary
Dr. Reddy's Laboratories sold its wholly-owned subsidiary, Svaas Wellness Limited. The sale was executed on April 7, 2026, for a consideration of ₹2.23 crore, with Enspirit Technology Services Private Limited as the buyer.
Apr 07 2026 19:04:00
About Dr Reddy's Laboratories.
NSE : 881
BSE : 500124
ISIN : INE089A01031
Dr Reddy's Laboratories. Management
| Name | Position |
|---|---|
| K Randhir Singh | Company Secretary, Compliance Officer and Head-CSR |
| K Satish Reddy | Chairman |
Dr Reddy's Laboratories. Similar Stocks
Sun Pharmaceutical Industries Ltd.
1680.10
10.30 (0.62%)
Divi's Laboratories Ltd.
6378.50
93.00 (1.48%)
Torrent Pharmaceuticals Ltd.
4147.20
62.60 (1.53%)
Apollo Hospitals Enterprise Ltd.
7781.00
119.00 (1.55%)
Lupin Ltd.
2341.40
33.50 (1.45%)
Cipla Ltd.
1305.90
69.60 (5.63%)
Max Healthcare Institute Ltd.
1006.75
1.40 (0.14%)
Lenskart Solutions Ltd.
537.90
-6.05 (1.11%)
Zydus Lifesciences Ltd.
946.35
16.45 (1.77%)
Mankind Pharma Ltd.
2292.90
57.90 (2.59%)
Dr Reddy's Laboratories. FAQs
The Buying Price of Dr Reddy's Laboratories. share is 1331 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Dr Reddy's Laboratories. stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dr Reddy's Laboratories., choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Dr Reddy's Laboratories. shares is 18.24. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Dr Reddy's Laboratories. shares is 2.73. Useful to assess the stock's value relative to its book value.
To assess Dr Reddy's Laboratories.’s valuation compare Sector P/E, P/B which are 64.34 & 3.51 with sector averages, along with growth rates and financial metrics.
The Market Cap of Dr Reddy's Laboratories. is 111090.99 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Dr Reddy's Laboratories. share price is 1379.70 & 1129.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Dr Reddy's Laboratories. belongs to the Healthcare sector.
